|
 |
商品名 |
|
|
商品名、賦形剤は国、製薬会社ごとに異なることがあります
|
|
Asinib |
メキシコ |
|
Axinotecan |
ドイツ |
|
Campto |
アイルランド, アラブ首長国連邦, イギリス, イタリア, イラン, インド, オランダ, オーストリア, ギリシア, クロアチア, スイス, スウェーデン, スペイン, タイ, チュニジア, デンマーク, トルコ, ノルウェー, ハンガリー, フィンランド, フランス, ベルギー, ポルトガル, ポーランド, マレーシア, モロッコ, ルクセンブルグ, 南アフリカ共和国, 日本 |
|
Camptosar |
アメリカ, カナダ, ブラジル |
|
Irinoliquid |
オーストリア |
|
Irnocam |
ブラジル |
|
|
 |
 |
引用文献 : Irinotecan |
|
|
形式 |
出版物 |
| 1423 |
雑誌 |
Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518. |
| 1617 |
雑誌 |
Li WY, Koda RT.
Stability of irinotecan hydrochloride in aqueous solutions.
Am J Health-Syst Pharm 2002 ; 59: 539-544. |
| 1662 |
雑誌 |
Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
J Oncol Pharm Practice 2002 ; 8: 33-37. |
| 1918 |
雑誌 |
Dodds HM, Craik DJ, Rivory LP.
Photodegradation of irinotecan (CPT-11) in aqueous solutions : identification of fluorescent products and influence of solution composition.
J Pharm Sci 1997 ; 86, 12: 1410-1416. |
| 1920 |
雑誌 |
Akimoto K, Kaway A, Ohya K et al.
Photodegradation reactions of CPT-11, a derivative of campothecion, part i: chemical structure of main degradation products in aqueous solution.
Drug Stability 1996 ; 1: 118-122. |
| 1921 |
雑誌 |
Akimoto K, Kawai A, Ohya K.
Photodegradation reactions of CPT-11, a derivative of campothecion, part ii: photodegradation behaviour of CPT-11 in aqueous solution.
Drug Stability 1996 ; 1; 141-146. |
| 1953 |
雑誌 |
Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293. |
| 1976 |
雑誌 |
Trissel LA, Xu QA.
Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated Y-site administration.
Int J Pharm Compound 2005 ; 9, 3: 238-241. |
| 2027 |
雑誌 |
Walker SE, Shirley L, Puodziunas A.
Simulation of Y-site compatibility of irinotecan and leucovorin at room temperature in 5% dextrose in water in 3 different containers.
Can J Hosp Pharm 2005 ; 58: 212-222. |
| 2143 |
雑誌 |
Dodds HM, Robert J, Rivory LP.
The detection of photodegradation products of irinotecan (CPT-11, Campto®, Camptosar®), in clinical studies, using high-performance liquid chromatography/atmospheric pressure chemical ionisation/mass spectrometry.
J Pharm Biomed Anal 1998 ; 17: 785-792. |
| 2168 |
雑誌 |
Ozdemir FA, Anilanmert B, Pekin M.
Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution.
Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534. |
| 2241 |
雑誌 |
Thiesen J, Krämer I.
Physicochemical stability of irinotecan injection concentrate and diluted infusion solutions in PVC bags.
J Oncol Pharm Practice 2000 ; 6, 3: 115-121. |
| 2340 |
雑誌 |
Walker S.E, Law S, Puodziunas A.
Simulation of Y-Site Compatibility of Irinotecan and Leucovorin at Room Temperature in 5% Dextrose in Water in 3 Different Containers
Can J Hosp Pharm 2005 ; 58, 4: 212-222. |
| 2671 |
雑誌 |
Kaiser J, Thiesen J, Krämer I.
Stability of irinotecan-loaded eluting beads (DC Bead) used for transarterial chemoembolization.
J Oncol Pharm Practice 2010 ; 16: 53-61. |
| 3129 |
実験 |
Irinotécan (Campto®) – Résumé des caractéristiques du produits
Pfizer 2008 |
| 3369 |
実験 |
Levofolinate de sodium Medac - Résumé des caractéristiques du produits
MEDAC France 2011 |
| 3670 |
雑誌 |
Sewell G, Massimini M.
Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system.
EJOP 2014 ; 8, 3: 26-30. |
| 3873 |
雑誌 |
Tan X, Hu J.
Incompatibility between irinotecan and fluorouracil injections
Am J Health-Syst Pharm 2016 ; 73:755. |
|
|
